Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
ESMO Congress 2026 · Barcelona, Spain
127 shown of 2,460 total abstracts
  1. Abstract 95912026-09-01 · 16:00 CT · Hall B1
    Real-world effectiveness of Opdivo vs standard of care in NSCLC
    R. Herbst, S. Peters, F. Andre, et al. · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  2. Abstract 98412026-09-02 · 14:30 CT · E450
    Quality of life outcomes with Keytruda in patients with SCLC
    H. Rugo, J. Brahmer, T. Mok, et al. · Princess Margaret Cancer Centre
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  3. Abstract 97192026-09-05 · 20:15 CT · Hall B1
    Long-term follow-up of Keytruda adjuvant for SCLC: KEYNOTE-876
    M.C. Garassino, R. Herbst, A. Spira · Peter MacCallum Cancer Centre
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  4. Abstract 99402026-09-04 · 14:30 CT · Arie Crown Theater
    Real-world effectiveness of Tecentriq vs standard of care in NSCLC
    M.C. Garassino, M. Krop, R. Herbst · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  5. Abstract 95912026-09-05 · 16:30 CT · Hall B1
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-511
    C. Saura, M. Reck, J. Cortes, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  6. Abstract 91322026-09-04 · 20:15 CT · Arie Crown Theater
    Real-world effectiveness of Tagrisso vs standard of care in NSCLC
    T. Mok, J. Brahmer, S. Antonia, et al. · Karolinska Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  7. Abstract 92342026-09-02 · 19:30 CT · Hall B1
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-997 study)
    A. Spira, E. Winer · Mayo Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  8. Abstract 92522026-09-02 · 13:00 CT · E450
    Quality of life outcomes with Tagrisso in patients with NSCLC
    C. Robert, L. Paz-Ares · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  9. Abstract 98682026-09-05 · 20:45 CT · Arie Crown Theater
    DESTINY-Breast-204: Enhertu (trastuzumab deruxtecan) adjuvant in NSCLC
    T. Mok, S. Antonia, L. Paz-Ares, et al. · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  10. Abstract 91962026-09-04 · 20:15 CT · S406
    Quality of life outcomes with Tecentriq in patients with NSCLC
    M. Reck, C. Robert, J. Brahmer, et al. · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  11. Abstract 98612026-09-04 · 19:45 CT · Hall B1
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-946
    J. Brahmer, L. Paz-Ares, C. Robert, et al. · Karolinska Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  12. Abstract 90842026-09-02 · 21:15 CT · Arie Crown Theater
    Quality of life outcomes with Enhertu in patients with NSCLC
    R. Herbst, H. Borghaei, F. Andre, et al. · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  13. Abstract 91272026-09-03 · 20:30 CT · E450
    Long-term follow-up of Keytruda maintenance for NSCLC: KEYNOTE-24
    J. Cortes, M. Reck, C. Robert · Royal Marsden Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  14. Abstract 95552026-09-03 · 15:45 CT · E450
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-60 study)
    P. Schmid, T. Mok, J. Cortes, et al. · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  15. Abstract 92212026-09-02 · 14:15 CT · Hall B1
    Quality of life outcomes with Imfinzi in patients with SCLC
    G. Curigliano, P. Schmid, F. Andre, et al. · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  16. Abstract 96352026-09-02 · 16:15 CT · Hall B1
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-940
    M. Reck, J. Brahmer, S. Modi, et al. · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  17. Abstract 92782026-09-04 · 18:00 CT · Hall B1
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-523 study)
    S. Tolaney, P. Schmid, E. Winer, et al. · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  18. Abstract 95082026-09-04 · 19:15 CT · S100A
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-513
    S. Antonia, M. Reck, A. Spira, et al. · Vall d'Hebron Institute of Oncology
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  19. Abstract 95512026-09-04 · 18:45 CT · S100A
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-913 study)
    S. Peters, J. Cortes, T. Mok · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  20. Abstract 97532026-09-01 · 21:30 CT · Hall B1
    CheckMate-250: Opdivo (nivolumab) adjuvant in NSCLC
    L. Paz-Ares, C. Saura, M. Reck, et al. · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  21. Abstract 90182026-09-01 · 21:00 CT · Hall B1
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-811 study)
    H. Rugo, C. Saura, S. Antonia, et al. · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  22. Abstract 91662026-09-01 · 20:30 CT · Hall B1
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-966
    C. Saura, G. Curigliano, J. Cortes, et al. · Princess Margaret Cancer Centre
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  23. Abstract 92902026-09-02 · 21:45 CT · Arie Crown Theater
    Quality of life outcomes with Keytruda in patients with NSCLC
    A. Spira, M.C. Garassino, J. Brahmer · Vall d'Hebron Institute of Oncology
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  24. Abstract 98332026-09-04 · 13:00 CT · Hall B1
    Long-term follow-up of Opdivo 3L+ for NSCLC: CheckMate-35
    R. Herbst, E. Winer, M. Krop, et al. · National Cancer Center Japan
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  25. Abstract 91012026-09-05 · 20:00 CT · Hall B1
    Long-term follow-up of Keytruda adjuvant for SCLC: KEYNOTE-772
    C. Robert, J. Brahmer, N. Rizvi, et al. · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  26. Abstract 96642026-09-02 · 19:30 CT · S100A
    FLAURA-761: Tagrisso (osimertinib) 1L in NSCLC
    J. Brahmer, T. Mok, N. Rizvi · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  27. Abstract 99132026-09-05 · 15:00 CT · Hall B1
    Long-term follow-up of Enhertu maintenance for NSCLC: DESTINY-Breast-591
    M. Reck, N. Rizvi, R. Herbst, et al. · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  28. Abstract 98242026-09-02 · 21:00 CT · Arie Crown Theater
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-594
    E. Winer, J. Cortes, J. Brahmer, et al. · Peter MacCallum Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  29. Abstract 94502026-09-04 · 18:30 CT · S406
    Long-term follow-up of Enhertu neoadjuvant for NSCLC: DESTINY-Breast-199
    A. Spira, S. Modi, H. Borghaei, et al. · National Cancer Center Japan
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  30. Abstract 98842026-09-05 · 16:00 CT · S100A
    CheckMate-554: Opdivo (nivolumab) 3L+ in NSCLC
    M. Reck, C. Robert, F. Andre, et al. · Mayo Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  31. Abstract 99462026-09-03 · 21:30 CT · E450
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-228 study)
    H. Rugo, S. Modi · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  32. Abstract 95332026-09-02 · 18:15 CT · S406
    KEYNOTE-987: Keytruda (pembrolizumab) neoadjuvant in NSCLC
    S. Tolaney, L. Paz-Ares · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  33. Abstract 96942026-09-02 · 20:00 CT · S100A
    Real-world effectiveness of Imfinzi vs standard of care in NSCLC
    J. Brahmer, C. Saura · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  34. Abstract 91772026-09-04 · 18:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-359 study)
    E. Winer, C. Robert, L. Paz-Ares · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  35. Abstract 91622026-09-04 · 20:45 CT · S100A
    Long-term follow-up of Tagrisso neoadjuvant for NSCLC: FLAURA-707
    R. Herbst, M.C. Garassino, N. Rizvi, et al. · Dana-Farber Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  36. Abstract 90302026-09-04 · 14:45 CT · Hall B1
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-363 study)
    M. Reck, G. Curigliano, S. Peters, et al. · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  37. Abstract 92852026-09-01 · 18:00 CT · Hall B1
    FLAURA-833: Tagrisso (osimertinib) 1L in NSCLC
    P. Schmid, J. Brahmer · Royal Marsden Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  38. Abstract 92822026-09-05 · 21:00 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-294
    H. Borghaei, F. Andre, H. Rugo · Mayo Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  39. Abstract 99592026-09-01 · 19:30 CT · Hall B1
    Long-term follow-up of Keytruda 1L for SCLC: KEYNOTE-965
    A. Spira, R. Herbst · National Cancer Center Japan
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  40. Abstract 92152026-09-02 · 16:15 CT · S100A
    Long-term follow-up of Imfinzi neoadjuvant for SCLC: PACIFIC-56
    C. Robert, F. Andre, J. Cortes · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  41. Abstract 99702026-09-03 · 16:00 CT · E450
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-616 study)
    J. Cortes, C. Robert · National Cancer Center Japan
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  42. Abstract 93332026-09-05 · 20:15 CT · Hall B1
    Long-term follow-up of Tagrisso maintenance for NSCLC: FLAURA-632
    H. Rugo, G. Curigliano · Peter MacCallum Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  43. Abstract 96882026-09-01 · 21:00 CT · S100A
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-12 study)
    F. Andre, L. Paz-Ares, J. Brahmer · Mayo Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  44. Abstract 98892026-09-03 · 18:00 CT · S100A
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-608
    J. Brahmer, G. Curigliano, M.C. Garassino · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  45. Abstract 98472026-09-05 · 19:45 CT · S406
    Long-term follow-up of Opdivo neoadjuvant for NSCLC: CheckMate-196
    M. Reck, N. Rizvi, F. Andre, et al. · Peter MacCallum Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  46. Abstract 93952026-09-02 · 13:00 CT · S406
    Long-term follow-up of Opdivo neoadjuvant for NSCLC: CheckMate-106
    J. Brahmer, M.C. Garassino, M. Krop · Royal Marsden Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  47. Abstract 94252026-09-03 · 21:45 CT · E450
    IMpower-283: Tecentriq (atezolizumab) neoadjuvant in NSCLC
    S. Antonia, H. Borghaei, H. Rugo, et al. · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  48. Abstract 95552026-09-02 · 19:15 CT · S100A
    Real-world effectiveness of Enhertu vs standard of care in NSCLC
    S. Peters, G. Curigliano · National Cancer Center Japan
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  49. Abstract 90412026-09-02 · 15:00 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-674
    P. Schmid, S. Tolaney, J. Brahmer · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  50. Abstract 98232026-09-01 · 14:00 CT · S100A
    Long-term follow-up of Tagrisso 3L+ for NSCLC: FLAURA-462
    S. Peters, C. Robert, J. Cortes, et al. · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  51. Abstract 90152026-09-03 · 16:30 CT · Hall B1
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-849 study)
    F. Andre, A. Spira, N. Rizvi, et al. · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  52. Abstract 95272026-09-05 · 14:15 CT · S100A
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-702 study)
    M. Krop, C. Robert, T. Mok, et al. · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  53. Abstract 93632026-09-02 · 18:45 CT · S100A
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-358
    P. Schmid, E. Winer, L. Paz-Ares, et al. · Vall d'Hebron Institute of Oncology
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  54. Abstract 97962026-09-02 · 20:15 CT · E450
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-856
    T. Mok, N. Rizvi, M. Krop · Karolinska Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  55. Abstract 99492026-09-02 · 20:15 CT · E450
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-725 study)
    C. Saura, S. Antonia, S. Modi, et al. · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  56. Abstract 95242026-09-05 · 19:45 CT · Hall B1
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-655 study)
    L. Paz-Ares, H. Rugo · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  57. Abstract 93692026-09-02 · 19:00 CT · S406
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-387 study)
    E. Winer, J. Cortes, L. Paz-Ares, et al. · Dana-Farber Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  58. Abstract 96202026-09-02 · 18:00 CT · S100A
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-687
    M. Krop, J. Brahmer, E. Winer, et al. · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  59. Abstract 92752026-09-03 · 16:00 CT · S100A
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-846
    S. Modi, S. Tolaney, M. Krop, et al. · Karolinska Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  60. Abstract 98472026-09-05 · 14:00 CT · Arie Crown Theater
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-155
    S. Modi, J. Brahmer, S. Antonia · University of Chicago
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  61. Abstract 96892026-09-05 · 14:15 CT · E450
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-92
    S. Modi, J. Brahmer, S. Tolaney, et al. · Peter MacCallum Cancer Centre
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  62. Abstract 96202026-09-02 · 21:45 CT · Arie Crown Theater
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-220
    S. Modi, M. Reck, N. Rizvi, et al. · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  63. Abstract 97772026-09-03 · 14:45 CT · E450
    FLAURA-639: Tagrisso (osimertinib) 3L+ in NSCLC
    R. Herbst, J. Cortes · National Cancer Center Japan
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  64. Abstract 98942026-09-02 · 21:15 CT · Hall B1
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-536
    M.C. Garassino, H. Borghaei, J. Cortes · Mayo Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  65. Abstract 93632026-09-05 · 14:00 CT · S406
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-523
    F. Andre, G. Curigliano, J. Cortes, et al. · Mayo Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  66. Abstract 90532026-09-04 · 21:00 CT · S100A
    FLAURA-194: Tagrisso (osimertinib) maintenance in NSCLC
    P. Schmid, S. Antonia, S. Tolaney, et al. · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  67. Abstract 94102026-09-02 · 21:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-482 study)
    P. Schmid, S. Peters · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  68. Abstract 99052026-09-02 · 20:45 CT · S406
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-147 study)
    C. Saura, T. Mok, E. Winer · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  69. Abstract 93562026-09-02 · 19:15 CT · E450
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-179 study)
    A. Spira, J. Brahmer · Karolinska Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  70. Abstract 90192026-09-03 · 14:15 CT · Hall B1
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-39
    J. Brahmer, H. Borghaei · Princess Margaret Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  71. Abstract 91362026-09-01 · 19:45 CT · Hall B1
    Quality of life outcomes with Imfinzi in patients with NSCLC
    G. Curigliano, C. Saura, S. Peters, et al. · MD Anderson Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  72. Abstract 99472026-09-02 · 13:45 CT · Hall B1
    Long-term follow-up of Imfinzi neoadjuvant for NSCLC: PACIFIC-388
    H. Rugo, J. Brahmer, A. Spira · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  73. Abstract 94142026-09-01 · 18:15 CT · Hall B1
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-473
    C. Saura, T. Mok, G. Curigliano · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  74. Abstract 97392026-09-05 · 13:45 CT · S100A
    Long-term follow-up of Opdivo maintenance for NSCLC: CheckMate-52
    A. Spira, H. Borghaei, R. Herbst, et al. · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  75. Abstract 93602026-09-01 · 19:45 CT · E450
    Long-term follow-up of Tecentriq 2L for NSCLC: IMpower-819
    R. Herbst, F. Andre, M. Reck, et al. · Royal Marsden Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  76. Abstract 96092026-09-04 · 20:45 CT · Arie Crown Theater
    Long-term follow-up of Tagrisso 3L+ for NSCLC: FLAURA-946
    S. Peters, J. Brahmer · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  77. Abstract 93112026-09-01 · 20:45 CT · S406
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-65 study)
    C. Saura, S. Modi, J. Cortes, et al. · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  78. Abstract 94582026-09-01 · 21:15 CT · E450
    KEYNOTE-70: Keytruda (pembrolizumab) adjuvant in NSCLC
    S. Peters, S. Modi, F. Andre · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  79. Abstract 94262026-09-04 · 21:30 CT · S100A
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-722 study)
    M. Krop, S. Antonia, M. Reck, et al. · Peter MacCallum Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  80. Abstract 94212026-09-02 · 16:30 CT · S406
    DESTINY-Breast-11: Enhertu (trastuzumab deruxtecan) neoadjuvant in NSCLC
    T. Mok, P. Schmid, L. Paz-Ares · Princess Margaret Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  81. Abstract 99172026-09-03 · 13:00 CT · E450
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-178 study)
    G. Curigliano, F. Andre, H. Rugo, et al. · Karolinska Institute
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  82. Abstract 93322026-09-03 · 18:00 CT · Hall B1
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-586 study)
    E. Winer, C. Saura, N. Rizvi · National Cancer Center Japan
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  83. Abstract 98892026-09-05 · 18:45 CT · Arie Crown Theater
    KEYNOTE-929: Keytruda (pembrolizumab) 3L+ in SCLC
    M. Krop, E. Winer, N. Rizvi · Royal Marsden Hospital
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  84. Abstract 98802026-09-05 · 16:45 CT · Hall B1
    DESTINY-Breast-428: Enhertu (trastuzumab deruxtecan) adjuvant in NSCLC
    S. Modi, M.C. Garassino, A. Spira · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  85. Abstract 99032026-09-04 · 15:45 CT · Hall B1
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-767
    M. Krop, L. Paz-Ares, S. Peters, et al. · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  86. Abstract 93052026-09-03 · 21:30 CT · S406
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-709 study)
    M. Reck, S. Peters, S. Antonia, et al. · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  87. Abstract 92292026-09-05 · 13:30 CT · E450
    IMpower-730: Tecentriq (atezolizumab) maintenance in NSCLC
    E. Winer, J. Cortes, S. Tolaney · Royal Marsden Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  88. Abstract 91782026-09-04 · 18:45 CT · S406
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-810
    C. Saura, M. Reck, C. Robert, et al. · Dana-Farber Cancer Institute
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  89. Abstract 98852026-09-05 · 20:45 CT · E450
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-372
    M. Krop, S. Peters, J. Brahmer · Royal Marsden Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  90. Abstract 91772026-09-04 · 21:45 CT · S100A
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-869 study)
    H. Rugo, M. Krop, S. Antonia · Karolinska Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  91. Abstract 91172026-09-01 · 18:15 CT · Hall B1
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-988 study)
    F. Andre, H. Rugo, M.C. Garassino, et al. · Peter MacCallum Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  92. Abstract 93452026-09-04 · 14:45 CT · S406
    Long-term follow-up of Opdivo 1L for NSCLC: CheckMate-186
    R. Herbst, H. Borghaei, H. Rugo · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  93. Abstract 99402026-09-04 · 18:15 CT · Hall B1
    Long-term follow-up of Keytruda 2L for SCLC: KEYNOTE-810
    J. Brahmer, T. Mok, S. Peters · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  94. Abstract 94662026-09-01 · 18:45 CT · Hall B1
    FLAURA-70: Tagrisso (osimertinib) 3L+ in NSCLC
    G. Curigliano, L. Paz-Ares, M. Reck, et al. · Princess Margaret Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  95. Abstract 94302026-09-03 · 19:30 CT · Hall B1
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-196 study)
    S. Antonia, F. Andre · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  96. Abstract 96842026-09-01 · 16:00 CT · Arie Crown Theater
    Long-term follow-up of Keytruda 3L+ for NSCLC: KEYNOTE-85
    S. Antonia, M. Krop, C. Saura, et al. · National Cancer Center Japan
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  97. Abstract 97052026-09-05 · 14:00 CT · Arie Crown Theater
    PACIFIC-402: Imfinzi (durvalumab) adjuvant in SCLC
    J. Brahmer, S. Antonia, N. Rizvi, et al. · Dana-Farber Cancer Institute
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  98. Abstract 95242026-09-02 · 15:45 CT · Arie Crown Theater
    Real-world effectiveness of Keytruda vs standard of care in NSCLC
    F. Andre, R. Herbst, S. Tolaney, et al. · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  99. Abstract 91172026-09-01 · 18:15 CT · S406
    FLAURA-484: Tagrisso (osimertinib) adjuvant in NSCLC
    M. Krop, A. Spira, G. Curigliano, et al. · Karolinska Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  100. Abstract 92442026-09-05 · 16:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-679 study)
    S. Peters, M.C. Garassino, N. Rizvi · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  101. Abstract 91572026-09-05 · 13:00 CT · E450
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-641
    S. Modi, A. Spira, R. Herbst · Mayo Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  102. Abstract 92812026-09-05 · 21:00 CT · S406
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-250
    E. Winer, H. Borghaei · Massachusetts General Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  103. Abstract 94412026-09-03 · 20:15 CT · E450
    Long-term follow-up of Tecentriq 3L+ for NSCLC: IMpower-26
    J. Cortes, P. Schmid, N. Rizvi · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  104. Abstract 92332026-09-01 · 14:30 CT · Hall B1
    Long-term follow-up of Tagrisso maintenance for NSCLC: FLAURA-613
    J. Cortes, S. Antonia · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  105. Abstract 93262026-09-05 · 16:15 CT · Arie Crown Theater
    Long-term follow-up of Opdivo 2L for NSCLC: CheckMate-330
    P. Schmid, S. Peters, C. Saura, et al. · Mayo Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  106. Abstract 94562026-09-04 · 19:30 CT · S100A
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-171 study)
    M. Krop, J. Cortes, M. Reck, et al. · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  107. Abstract 91162026-09-01 · 15:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-145 study)
    M.C. Garassino, H. Rugo, E. Winer, et al. · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  108. Abstract 90702026-09-02 · 19:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-254 study)
    M. Krop, R. Herbst, S. Tolaney, et al. · Massachusetts General Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  109. Abstract 99442026-09-05 · 19:30 CT · S100A
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-30 study)
    S. Tolaney, L. Paz-Ares, S. Antonia · Princess Margaret Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  110. Abstract 91782026-09-03 · 21:00 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-511 study)
    H. Borghaei, J. Brahmer, G. Curigliano · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  111. Abstract 98652026-09-05 · 20:15 CT · E450
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-622 study)
    A. Spira, M.C. Garassino · Vall d'Hebron Institute of Oncology
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  112. Abstract 90232026-09-01 · 20:45 CT · S406
    Long-term follow-up of Tecentriq 2L for NSCLC: IMpower-573
    T. Mok, C. Saura, A. Spira, et al. · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  113. Abstract 99092026-09-01 · 19:30 CT · Hall B1
    Long-term follow-up of Opdivo maintenance for NSCLC: CheckMate-806
    J. Brahmer, T. Mok, R. Herbst · Vall d'Hebron Institute of Oncology
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  114. Abstract 91732026-09-02 · 16:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-824 study)
    J. Cortes, A. Spira · Mayo Clinic
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  115. Abstract 93832026-09-04 · 13:00 CT · Arie Crown Theater
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-387
    G. Curigliano, E. Winer, S. Peters · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  116. Abstract 97902026-09-03 · 15:30 CT · Hall B1
    FLAURA-514: Tagrisso (osimertinib) neoadjuvant in NSCLC
    R. Herbst, N. Rizvi, L. Paz-Ares, et al. · Princess Margaret Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  117. Abstract 97742026-09-05 · 18:30 CT · S406
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-797 study)
    S. Antonia, A. Spira · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  118. Abstract 96842026-09-04 · 21:00 CT · E450
    Long-term follow-up of Keytruda 1L for SCLC: KEYNOTE-380
    E. Winer, T. Mok, M. Krop, et al. · University of Chicago
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  119. Abstract 93182026-09-04 · 20:30 CT · E450
    Long-term follow-up of Tagrisso maintenance for NSCLC: FLAURA-771
    S. Peters, L. Paz-Ares · Massachusetts General Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  120. Abstract 99602026-09-05 · 14:15 CT · Arie Crown Theater
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-70
    C. Saura, P. Schmid, T. Mok, et al. · National Cancer Center Japan
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  121. Abstract 96692026-09-02 · 18:00 CT · Hall B1
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-159
    T. Mok, N. Rizvi, H. Borghaei, et al. · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  122. Abstract 98892026-09-01 · 13:45 CT · S406
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-720
    M. Krop, A. Spira, H. Borghaei · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  123. Abstract 94262026-09-05 · 20:30 CT · Hall B1
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-983 study)
    R. Herbst, N. Rizvi, J. Brahmer, et al. · Karolinska Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  124. Abstract 97162026-09-04 · 15:00 CT · S406
    Quality of life outcomes with Opdivo in patients with NSCLC
    A. Spira, R. Herbst, M.C. Garassino · Vall d'Hebron Institute of Oncology
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  125. Abstract 92062026-09-05 · 19:45 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-990 study)
    A. Spira, S. Antonia, C. Saura, et al. · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  126. Abstract 96802026-09-01 · 19:45 CT · E450
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-137
    S. Peters, S. Tolaney, M.C. Garassino · Mayo Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  127. Abstract 97172026-09-03 · 18:00 CT · S406
    Long-term follow-up of Tagrisso 3L+ for NSCLC: FLAURA-609
    G. Curigliano, S. Tolaney, L. Paz-Ares, et al. · Mayo Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.